The GORAB Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population designed for targeted disruption of the GORAB gene in the HAP1 cell line. This product offers a powerful loss-of-function model for studying the cellular roles of GORAB in Golgi stack organization and protein glycosylation. The polyclonal format provides a heterogeneous population of knockout cells, enabling robust and representative downstream analyses without clonal bias. By employing CRISPR/Cas9-mediated gene disruption, these cells enable researchers to dissect GORAB-dependent biological processes with high relevance to human physiology.
The HAP1 cell line is a near-haploid, fibroblast-like cell line derived from the KBM-7 chronic myeloid leukemia background. Its near-haploid karyotype simplifies genetic manipulation and knockout generation, making it a widely adopted platform for functional genomics and CRISPR-based screening. HAP1 cells retain key cellular pathways and are particularly suited for studying fundamental processes such as protein trafficking, secretion, and organelle biology. The near-haploid nature minimizes off-target effects from multiple alleles, providing a clean system for investigating GORAB loss-of-function phenotypes.
GORAB encodes a trans-Golgi protein critical for Golgi stack architecture and efficient protein glycosylation. Mechanistically, GORAB interacts with the SCYL1 adaptor protein and components of the COPI coat complex, including ARF1, to regulate vesicular trafficking and cargo processing within the Golgi. Upstream regulators such as SCYL1 and Rab GTPases modulate GORAB function, while downstream targets include glycoproteins and extracellular matrix components that depend on proper glycosylation for secretion and function. Disruption of GORAB leads to impaired Golgi morphology, defective glycosylation, and altered secretion dynamics, underscoring its central role in secretory pathway homeostasis.
In the context of the HAP1 near-haploid background, the GORAB knockout model provides a powerful tool for dissecting Golgi-dependent cellular processes. The loss of GORAB recapitulates cellular deficits observed in geroderma osteodysplasticum, a rare connective tissue disorder characterized by skin laxity and skeletal abnormalities linked to glycosylation defects. This model enables the study of disease mechanisms in a human cell system, facilitating the exploration of therapeutic strategies or compensatory pathways. The polyclonal nature of the knockout population enhances reproducibility and allows for the analysis of heterogeneous cellular responses, valuable for assessing subtle phenotypic variations in secretion or Golgi organization.
These GORAB knockout cells are ideal for a wide range of experimental applications, including immunofluorescence microscopy to visualize Golgi structure, Western blotting and lectin binding assays to evaluate protein glycosylation status, and secretion assays to measure extracellular release of glycosylated cargo. Co-immunoprecipitation studies can further map GORAB interactions with SCYL1 and COPI components. Researchers focused on Golgi biology, protein glycosylation disorders, geroderma osteodysplasticum pathogenesis, or general secretory mechanisms will find this model invaluable for generating functional insights. For more information or to discuss custom applications, please contact Ascent Research.
